Cargando…
Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer
Prostate cancer possesses several characteristics that make it a suitable candidate for immunotherapy; however, prostate cancer vaccines to date demonstrate modest efficacy and low immunogenicity. The goal of the present pre-clinical study was to explore the immunogenic properties and protective eff...
Autores principales: | Cappuccini, Federica, Stribbling, Stephen, Pollock, Emily, Hill, Adrian V. S., Redchenko, Irina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880633/ https://www.ncbi.nlm.nih.gov/pubmed/27052571 http://dx.doi.org/10.1007/s00262-016-1831-8 |
Ejemplares similares
-
5T4 oncofoetal glycoprotein: an old target for a novel prostate cancer immunotherapy
por: Cappuccini, Federica, et al.
Publicado: (2017) -
Simian adenoviruses as vaccine vectors
por: Morris, Susan J, et al.
Publicado: (2016) -
HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
por: Capucci, Silvia, et al.
Publicado: (2017) -
Correction: HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
por: Capucci, Silvia, et al.
Publicado: (2023) -
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
por: Folegatti, Pedro M., et al.
Publicado: (2019)